Bayer Corp FDA Record
- Latest inspection VAI · Mar 20, 2025
- Last warning letter 2017
Bayer Corp has 1 FDA recall, 40 inspections, 96 510(k) clearances and 2 compliance actions on record. FDA has issued 2 warning letters to Bayer Corp, the most recent on Nov 14, 2017.
- Latest recall
- Z-3147-2026 · Jul 31, 2026 · filed under Bayer Medical Care
- Latest recall under this name
- Z-1673-2014 · Class II · Apr 3, 2014
- Latest inspection
- Mar 20, 2025 · VAI
- Latest 510(k)
- Mar 3, 2003
Newer recall under related name Bayer Medical Care: Jul 31, 2026, Z-3147-2026.
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 1 | Drug: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Device: Nov 20, 2026 (checked Nov 22, 2026, unchanged); Food: Nov 22, 2026 | Drug: File dated Nov 19, 2026; Device: File dated Nov 19, 2026; Food: File dated Nov 19, 2026 | Current |
| 510(k) clearances | 96 | Nov 22, 2026 | File dated Nov 18, 2026 | Current |
| Inspections | 40 | Nov 22, 2026 | Newest record Nov 9, 2026 | Current |
| Compliance actions | 2 | Nov 22, 2026 | Newest record Nov 13, 2026 | Current |
FDA record by year
Bayer Corp: FDA inspections per year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 1 | 0 | 0 | 0 | 0 |
| 2024 | 2 | 0 | 0 | 0 | 0 |
| 2023 | 3 | 0 | 0 | 0 | 0 |
| 2022 | 1 | 0 | 0 | 0 | 0 |
| 2021 | 1 | 0 | 0 | 0 | 0 |
| 2020 | 1 | 0 | 0 | 0 | 0 |
| 2019 | 4 | 1 | 0 | 0 | 0 |
| 2018 | 3 | 0 | 0 | 0 | 0 |
| 2017 | 2 | 1 | 1 | 0 | 0 |
Reviewing Bayer Corp as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Bayer Corp yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Bayer Corp FDA Warning Letters
| Issued | Subject | Issuing office | Close-out letter |
|---|---|---|---|
| Nov 14, 2017 · Record page | |||
| Aug 5, 2009 · Record page |
Recent recalls
| Number | Class | Product | Date |
|---|---|---|---|
| Z-1673-2014 | Class II | Medrad Continuum MR Infusion system- non-wireless system The MEDRAD Continuum MR Infusion System… | Apr 3, 2014 |
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Mar 20, 2025 | Leverkusen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806462 |
| Nov 14, 2024 | Bergkamen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002808084 |
| Jun 6, 2024 | Berlin, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002808086 |
| Sep 15, 2023 | Turku, Finland | Drugs | Voluntary Action Indicated (VAI) | 1000350927 |
| Sep 7, 2023 | Leverkusen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806462 |
| Jan 18, 2023 | Wuppertal, Germany | Drugs | Voluntary Action Indicated (VAI) | 3003229486 |
| May 13, 2022 | Leverkusen, Germany | Drugs | No Action Indicated (NAI) | 3002806462 |
| Aug 27, 2021 | Berlin, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002808086 |
| Jul 27, 2020 | Leverkusen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002806462 |
| Oct 10, 2019 | Bergkamen, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002808084 |
| Sep 24, 2019 | Berlin, Germany | Drugs | Voluntary Action Indicated (VAI) | 3002808086 |
| Jul 11, 2019 | Wuppertal, Germany | Drugs | Voluntary Action Indicated (VAI) | 3003229486 |
| Mar 22, 2019 | Leverkusen, Germany | Drugs | Official Action Indicated (OAI) | 3002806462 |
| Jun 29, 2018 | Wuppertal, Germany | Drugs | No Action Indicated (NAI) | 3003229486 |
| Jun 15, 2018 | Bergkamen, Germany | Drugs | No Action Indicated (NAI) | 3002808084 |
| Jun 1, 2018 | Turku, Finland | Devices | No Action Indicated (NAI) | 1000350927 |
| Jan 24, 2017 | Berlin, Germany | Drugs | No Action Indicated (NAI) | 3002808086 |
| Jan 20, 2017 | Leverkusen, Germany | Drugs | Official Action Indicated (OAI) | 3002806462 |
| Jun 3, 2016 | Leverkusen, Germany | Drugs | No Action Indicated (NAI) | 3002806462 |
| Apr 15, 2016 | Turku, Finland | Drugs | Voluntary Action Indicated (VAI) | 1000350927 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
Compliance Actions
FDA's compliance actions data lists 2 compliance actions under Bayer Corp: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3002806462 | Leverkusen, Germany | 10 | Mar 20, 2025 |
| FEI 3002808084 | Bergkamen, Germany | 7 | Nov 14, 2024 |
| FEI 3002808086 | Berlin, Germany | 9 | Jun 6, 2024 |
| FEI 1000350927 | Turku, Finland | 6 | Sep 15, 2023 |
| FEI 3003229486 | Wuppertal, Germany | 8 | Jan 18, 2023 |
Recent 510(k) clearances
| K-Number | Device | Date |
|---|---|---|
| K024062 | ASCENSIA BREEZE BLOOD GLUCOSE METER | Mar 3, 2003 |
| K023944 | BAYER DIAGNOSTICS CLINITEST PREGNANCY TEST | Feb 11, 2003 |
| K024017 | BAYER ADVIA CENTAUR HER-2/NEU ASSAY | Jan 30, 2003 |
| K024234 | ASCENSIA GLUCOFACTS; ASCENSIA GLUCOFACTS PROFESSIONAL | Jan 23, 2003 |
| K022288 | COMPLEXED PROSTATE SPECIFIC ANTIGEN (CPSA) ASSAY FOR THE BAYER ADVIA INTEGRATED MODULE SYSTEM | Dec 17, 2002 |
| K023584 | ASCENSIA DEX 2 DIABETES CARE SYSTEM | Nov 20, 2002 |
| K020828 | CA 125 ASSAY FOR THE ADVIA CENTAUR SYSTEM | Jul 24, 2002 |
| K021428 | CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEM | Jul 5, 2002 |
| K020806 | ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY | Mar 27, 2002 |
| K013568 | CEA ASSAY FOR THE ADVIA INTEGRATED MODULAR SYSTEM | Dec 21, 2001 |
| K012337 | BAYER ADVIA IMS SYSTEM; C-REACTIVE PROTEIN SYSTEM | Dec 6, 2001 |
| K011963 | ADVIA 1650 GLUCOSE HEXOKINASE 11 ASSAY | Nov 20, 2001 |
| K013272 | ACS: 180 AND ADVIA CENTAUR THEOPHYLLINE 2 ASSAY | Oct 25, 2001 |
| K012777 | ACS: 180 AND ADVIA CENTAUR ANTI-THYROGLOBULIN IMMUNOASSAYS | Oct 22, 2001 |
| K012340 | BAYER ADVIA SYSTEM; UNSATURATED IRON BINDING CAPACITY (UIBC) | Oct 1, 2001 |
| K012205 | GLUCOMETER DEX TEST SENSOR | Sep 12, 2001 |
| K010755 | BAYER DIAGNOSTICS ADVIA CENTAUR TOXOPLASMA IGM ASSAY | Aug 20, 2001 |
| K010668 | BAYER DIAGNOSTICS ADVIA CENTAUR RUBELLA IGM ASSAY | Jul 5, 2001 |
| K003412 | ADVIA CENTAUR RUBELLA IGG ASSAY | Apr 13, 2001 |
| K010201 | BAYER ADVIA IMS SYSTEM | Mar 29, 2001 |
Bayer Corp and the FDA: common questions
Has Bayer Corp received an FDA warning letter?
Yes. FDA has issued 2 warning letters to Bayer Corp. The most recent is dated Nov 14, 2017.
Has Bayer Corp received an FDA Form 483?
FDA has not published a Form 483 for "Bayer Corp" in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Bayer Corp?
The most recent FDA inspection on file ended Mar 20, 2025 at Leverkusen, Germany and was classified VAI. FDA has 40 inspections of Bayer Corp on file, 3 of them classified OAI (official action indicated).
Has Bayer Corp had an FDA recall?
Yes. Bayer Corp has 1 FDA recall on record. The most recent under this name started Apr 3, 2014. A newer recall, dated Jul 31, 2026, is filed under the related name Bayer Medical Care.
Need more than this page shows? Ask about Bayer Corp in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.